Last 1,000 GBp
Change Today -11.00 / -1.09%
Volume 9.2K
CSRT On Other Exchanges
Symbol
Exchange
OTC US
London
OTC US
As of 11:35 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

consort medical plc (CSRT) Snapshot

Open
1,006 GBp
Previous Close
1,011 GBp
Day High
1,008 GBp
Day Low
998.00 GBp
52 Week High
02/3/14 - 1,113 GBp
52 Week Low
09/23/13 - 840.00 GBp
Market Cap
292.9M
Average Volume 10 Days
67.7K
EPS TTM
0.45 GBp
Shares Outstanding
29.3M
EX-Date
09/17/14
P/E TM
22.2x
Dividend
23.00 GBp
Dividend Yield
2.30%
Current Stock Chart for CONSORT MEDICAL PLC (CSRT)

Related News

No related news articles were found.

consort medical plc (CSRT) Related Businessweek News

No Related Businessweek News Found

consort medical plc (CSRT) Details

Consort Medical plc designs, develops, manufactures, and sells specialty medical drug delivery devices and services to the pharmaceutical industry in Europe, the United Kingdom, the United States, and internationally. It offers metered dose inhaler valves, dry powder inhalers, integrated dose counters, actuators, disposable auto injectors, needle-free reusable jet injectors, video laryngoscopes, nasal drug delivery devices, nicotine inhalation devices, point of care diagnostics devices, and medical check valves to treat asthma and chronic obstructive pulmonary diseases. The company also manufactures anodized parts and pressings. Consort Medical plc is based in Hemel Hempstead, the United Kingdom.

657 Employees
Last Reported Date: 07/30/14

consort medical plc (CSRT) Top Compensated Officers

Chief Executive Officer, Director, Member of ...
Total Annual Compensation: 834.0K GBP
Chief Financial Officer, Group Finance Direct...
Total Annual Compensation: 465.0K GBP
Compensation as of Fiscal Year 2014.

consort medical plc (CSRT) Key Developments

Consort Medical plc. Approves Final Dividend

Consort Medical plc announced that at the Annual General Meeting held on 4 September 2014 approved to declare a final dividend of 13.35 p per ordinary share.

Consort Medical plc announces Directorate Changes

Consort Medical plc announced the appointment of Andrew Hosty as a non executive director of the company, effective immediately. Mr. Hosty joins the Nomination, Audit and Remuneration Committees. Following the appointment of Andrew Hosty, and as previously highlighted on 1 April 2014, Dr. Lynn Drummond has now stepped down from the Board. Andrew Hosty is Chief Operating Officer at Morgan Advanced Materials plc, an appointment he has held since February 2013.

Consort Medical Plc. Proposes Final Dividend, Payable on October 24, 2014; Announces Audited Consolidated Earnings Results for the Year Ended April 30, 2014

Consort Medical plc announced that its Board is proposing a final dividend per share of 13.35 pence such that the total dividend for the period amounts to 20.7 pence. The final dividend will be paid on October 24, 2014 to shareholders on the register on September 19, 2014. The company also announced audited consolidated earnings results for the year ended April 30, 2014. For the year, the company reported revenue of GBP 100,010,000 against GBP 95,044,000 a year ago. Operating profit was GBP 17,406,000 against GBP 16,556,000 a year ago. Profit before tax was GBP 16,140,000 against GBP 14,395,000 a year ago. Profit for the financial year from continuing operations was GBP 13,646,000 or 46.2 pence per diluted share against GBP 10,887,000 or 36.8 pence per diluted share a year ago. Profit for the financial year was GBP 12,968,000 or 43.9 pence per diluted share against GBP 24,184,000 or 81.7 pence per diluted share a year ago. Adjusted diluted earnings per ordinary share were 47.1 pence against 43.2 pence a year ago. Net cash inflow from operating activities was GBP 13,771,000 against GBP 20,015,000 a year ago. Purchases of property, plant and equipment were GBP 16,134,000 against GBP 9,969,000 a year ago. Purchases of intangible assets were GBP 158,000 against GBP 1,024,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSRT:LN 1,000.00 GBp -11.00

CSRT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Carclo PLC 128.00 GBp -2.75
Gerresheimer AG €56.20 EUR +0.76
Rexam PLC 505.50 GBp -4.50
West Pharmaceutical Services Inc $44.79 USD -0.10
View Industry Companies
 

Industry Analysis

CSRT

Industry Average

Valuation CSRT Industry Range
Price/Earnings 20.9x
Price/Sales 2.8x
Price/Book 2.3x
Price/Cash Flow 14.5x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONSORT MEDICAL PLC, please visit www.consortmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.